• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

土耳其间质性肺疾病的流行病学与分布情况

Epidemiology and distribution of interstitial lung diseases in Turkey.

作者信息

Musellim Benan, Okumus Gulfer, Uzaslan Esra, Akgün Metin, Cetinkaya Erdogan, Turan Onur, Akkoclu Atila, Hazar Armagan, Kokturk Nurdan, Calisir Haluk Celalettin

机构信息

Department of Pulmonary Diseases, Cerrahpasa Medical Faculty, Istanbul University, İstanbul, Turkey.

出版信息

Clin Respir J. 2014 Jan;8(1):55-62. doi: 10.1111/crj.12035. Epub 2013 Jul 31.

DOI:10.1111/crj.12035
PMID:23711298
Abstract

INTRODUCTION

There is very few data on the epidemiological features of interstitial lung diseases (ILD) in the literature. These studies on this subject suffer from limited number of patients.

OBJECTIVE

The goal of this study was to evaluate the epidemiological features of ILD in Turkey.

METHODS

Fifty-four investigators, 31 centres in 19 cities from six regions of Turkey, participated in the study. Two thousand two hundred forty-five newly diagnosed patients (51.8% females), led by Turkish Thoracic Society Clinical Problems Study Group, enrolled in this prospective study.

RESULTS

The mean age was 51.8 ± 16.7 years. The mean age among males was 50.5 ± 18.6 years and 53.0 ± 14.6 years among females (P < 0.001). 23.8% of the cases had ILD with known causes, while 39.4% were in granulomatous group, 23.7% were idiopathic, and 4.4% were in the unclassified group. Overall, histopathologically confirmed diagnosis rate was 40.4%. Sarcoidosis was the most common disease (37%), whereas cases with idiopathic pulmonary fibrosis (IPF) constituted 19,9% of patients. 53% of the sarcoidosis patients were females, and the ratio reaches to 75% under 50 years of age (for this group, IPF ratio is %3). In contrast, sarcoidosis and IPF ratios were equal in males (25%). Sarcoidosis was 8% in men over 50, while IPF was %45.

CONCLUSION

The overall incidence of ILD in Turkey was computed to be 25.8/100,000.

摘要

引言

文献中关于间质性肺疾病(ILD)流行病学特征的数据非常少。这些关于该主题的研究患者数量有限。

目的

本研究的目的是评估土耳其ILD的流行病学特征。

方法

来自土耳其六个地区19个城市的31个中心的54名研究人员参与了该研究。由土耳其胸科学会临床问题研究小组牵头,2245名新诊断患者(51.8%为女性)纳入了这项前瞻性研究。

结果

平均年龄为51.8±16.7岁。男性的平均年龄为50.5±18.6岁,女性为53.0±14.6岁(P<0.001)。23.8%的病例患有已知病因的ILD,而39.4%属于肉芽肿组,23.7%为特发性,4.4%属于未分类组。总体而言,组织病理学确诊率为40.4%。结节病是最常见的疾病(37%),而特发性肺纤维化(IPF)患者占19.9%。53%的结节病患者为女性,则50岁以下这一比例达到75%(该组中,IPF比例为3%)。相比之下,男性中结节病和IPF的比例相等(25%)。50岁以上男性中结节病占8%,而IPF占45%。

结论

据计算,土耳其ILD的总体发病率为25.8/10万。

相似文献

1
Epidemiology and distribution of interstitial lung diseases in Turkey.土耳其间质性肺疾病的流行病学与分布情况
Clin Respir J. 2014 Jan;8(1):55-62. doi: 10.1111/crj.12035. Epub 2013 Jul 31.
2
A cohort study of interstitial lung diseases in central Denmark.丹麦中部间质性肺疾病的队列研究。
Respir Med. 2014 May;108(5):793-9. doi: 10.1016/j.rmed.2013.09.002. Epub 2013 Sep 20.
3
[Interstitial lung diseases among patients hospitalized in the Department of Respiratory Medicine in Radom District Hospital during the years 2000-2009].[2000年至2009年期间拉多姆地区医院呼吸内科住院患者的间质性肺疾病]
Pneumonol Alergol Pol. 2012;80(6):523-32.
4
Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung.与吸烟有关的肺气肿与特发性肺纤维化和类风湿肺有关。
Respirology. 2013 Nov;18(8):1191-6. doi: 10.1111/resp.12154.
5
Epidemiological features of Turkish patients with sarcoidosis.土耳其结节病患者的流行病学特征。
Respir Med. 2009 Jun;103(6):907-12. doi: 10.1016/j.rmed.2008.12.011. Epub 2009 Feb 1.
6
[The evaluation of 92 interstitial lung disease patients].[92例间质性肺疾病患者的评估]
Tuberk Toraks. 2009;57(3):314-26.
7
[Epidemiology of interstitial lung diseases].[间质性肺疾病的流行病学]
Presse Med. 2010 Jan;39(1):53-9. doi: 10.1016/j.lpm.2009.09.015. Epub 2009 Dec 4.
8
Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.加拿大肺纤维化注册研究中的基线特征和合并症。
BMC Pulm Med. 2019 Nov 27;19(1):223. doi: 10.1186/s12890-019-0986-4.
9
Estimating the incidence of interstitial lung diseases in the Cree of Eeyou Istchee, northern Québec.估算魁北克北部伊尤伊斯切地区克里族间质性肺疾病的发病率。
PLoS One. 2017 Sep 8;12(9):e0184548. doi: 10.1371/journal.pone.0184548. eCollection 2017.
10
Clubbing in patients with fibrotic interstitial lung diseases.肺纤维化性间质性肺疾病患者的杵状指。
Respir Med. 2017 Nov;132:226-231. doi: 10.1016/j.rmed.2017.10.021. Epub 2017 Nov 2.

引用本文的文献

1
Hypersensitivity pneumonitis in Türkiye: An underrecognized pulmonary disorder.土耳其的过敏性肺炎:一种未得到充分认识的肺部疾病。
Sarcoidosis Vasc Diffuse Lung Dis. 2025 Jun 25;42(2):15884. doi: 10.36141/svdld.v42i2.15884.
2
The Frequency of Mediastinal Lymph Node Calcification in Sarcoidosis Patients and the Influencing Factors.结节病患者纵隔淋巴结钙化的发生率及影响因素
Medicina (Kaunas). 2024 Dec 25;61(1):8. doi: 10.3390/medicina61010008.
3
The role of biomarkers in the diagnosis and treatment follow-up of idiopathic pulmonary fibrosis.
生物标志物在特发性肺纤维化诊断及治疗随访中的作用
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Jun 28;41(2):e2024015. doi: 10.36141/svdld.v41i2.15454.
4
Relative incidence of interstitial lung diseases in Brazil.巴西间质性肺病的相对发病率。
J Bras Pneumol. 2024 Mar 22;50(1):e20230232. doi: 10.36416/1806-3756/e20230232. eCollection 2024.
5
Prevalence, incidence, and survival analysis of interstitial lung diseases in Hong Kong: a 16-year population-based cohort study.香港间质性肺疾病的患病率、发病率及生存分析:一项基于人群的16年队列研究。
Lancet Reg Health West Pac. 2023 Aug 10;42:100871. doi: 10.1016/j.lanwpc.2023.100871. eCollection 2024 Jan.
6
Home-Based Physiotherapy and Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis: A Review.特发性肺纤维化患者的家庭物理治疗与康复:综述
Thorac Res Pract. 2023 May;24(3):170-176. doi: 10.5152/ThoracResPract.2023.22150.
7
Humoral and Cellular Immunity to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in Patients with Sarcoidosis.结节病患者对严重急性呼吸综合征冠状病毒 2 疫苗接种的体液和细胞免疫。
Balkan Med J. 2023 Jan 23;40(1):34-39. doi: 10.4274/balkanmedj.galenos.2022.2022-8-64. Epub 2022 Dec 9.
8
Incidence, prevalence, and national burden of interstitial lung diseases in India: Estimates from two studies of 3089 subjects.印度间质性肺疾病的发病率、患病率和全国负担:两项 3089 例受试者研究的估计值。
PLoS One. 2022 Jul 21;17(7):e0271665. doi: 10.1371/journal.pone.0271665. eCollection 2022.
9
Research Burden of Interstitial Lung Diseases in Turkey - RBILD.土耳其间质性肺疾病的研究负担——RBILD
Sarcoidosis Vasc Diffuse Lung Dis. 2022;39(1):e2022006. doi: 10.36141/svdld.v39i1.12269. Epub 2022 Mar 31.
10
Variability in Global Prevalence of Interstitial Lung Disease.间质性肺疾病全球患病率的变异性。
Front Med (Lausanne). 2021 Nov 4;8:751181. doi: 10.3389/fmed.2021.751181. eCollection 2021.